Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aromatherapy for Chemotherapy-Induced Symptoms
NCT02670941Phase 1Terminated
- Sponsor
- University of Rochester
- Start
- Jan 2016
- Primary completion
- Sep 2018
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Not applicable, sponsored by University of Rochester. Primary endpoint: Mean change in severity in symptoms at 11 weeks. Started Jan 2016; status: terminated.
02
Conditions
Not applicable
Beyond the preview
Go deeper on NCT02670941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02670941.